These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15527851)

  • 1. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
    Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
    Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases.
    Blumenzweig I; Baraz L; Friedler A; Danielson UH; Gilon C; Steinitz M; Kotler M
    Biochem Biophys Res Commun; 2002 Apr; 292(4):832-40. PubMed ID: 11944889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region.
    Baraz L; Hutoran M; Blumenzweig I; Katzenellenbogen M; Friedler A; Gilon C; Steinitz M; Kotler M
    J Gen Virol; 2002 Sep; 83(Pt 9):2225-2230. PubMed ID: 12185277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
    Baraz L; Friedler A; Blumenzweig I; Nussinuv O; Chen N; Steinitz M; Gilon C; Kotler M
    FEBS Lett; 1998 Dec; 441(3):419-26. PubMed ID: 9891983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein.
    Friedler A; Zakai N; Karni O; Friedler D; Gilon C; Loyter A
    J Mol Biol; 1999 Jun; 289(3):431-7. PubMed ID: 10356319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.
    Kotler M; Simm M; Zhao YS; Sova P; Chao W; Ohnona SF; Roller R; Krachmarov C; Potash MJ; Volsky DJ
    J Virol; 1997 Aug; 71(8):5774-81. PubMed ID: 9223465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.
    Cancio R; Spadari S; Maga G
    Biochem J; 2004 Nov; 383(Pt. 3):475-82. PubMed ID: 15315477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Sakamoto A; Ishikawa K; Inagaki Y; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D; Takaku H
    Biochem Biophys Res Commun; 2004 Jul; 320(2):544-50. PubMed ID: 15219863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of the vif gene of human immunodeficiency virus type 1 in Escherichia coli and study of the immunoreactivity of the vif protein].
    Karaseva NG; Gibadulin RA; Kiselev SI; Karamov EV
    Mol Gen Mikrobiol Virusol; 1993; (5):26-9. PubMed ID: 8289843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
    Wondrak EM; Louis JM
    Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease.
    Adekale MA; Cane PA; McCrae MA
    J Med Virol; 2005 Feb; 75(2):195-201. PubMed ID: 15602725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
    Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.
    Ochsenbauer C; Bosch V; Oelze I; Wieland U
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1389-95. PubMed ID: 8757978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
    Chan WE; Chen SS
    Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.